21 May 2009
Polymorphisms of MDR1 gene in renal transplant patients and healthy controls
M Wagner, M Magott-Procelewska, Ł Fiszer-Maliszewska, I Nowak, W Niepiekło, J Padzik, A Wiśniewski, B Nowakowska, P KuśnierczykAnn Transplant 2009; 14(1): 60-60 :: ID: 880416
Abstract
Background: P-glycoprotein encoded by MDR1 (ABCB1) gene acts as a transmembrane transporter for a great number of xenobiotics, including immunosuppressive drugs used in treatment of renal transplant patients. Some of MDR1 gene polymorphisms are reported to affect P-glycoprotein activity, thus, they may influence renal graft survival.
Material/Methods: A total of 98 renal transplant recipients and 260 healthy
individuals were studied for three MDR1 polymorphisms determining major
haplotypes in Caucasian population, 1236C>T, 2677G>T/A and 3435C>T.
Genotyping was based on PCR-RFLP analysis. Phase program was used for
haplotype analysis. Frequencies of alleles, genotypes and haplotypes were
analyzed by Chi-square test with Yates correction.
Results: Allelic frequency and genotype distribution were similar in control and patient groups, except for a significant difference noted between control and a patient subgroup with no sign of graft rejection in a case of the variant 3435C>T. Distribution of haplotypes 1236-2677-3435 and major diplotypes also markedly differed between these two groups.
Conclusions: The preliminary data on MDR1 polymorphisms, major haplotypes and diplotypes among renal transplant patients suggest their potential association with some clinical observations.
Keywords: Kidney Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860